These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

493 related articles for article (PubMed ID: 33763029)

  • 1. Impact of Ramadan Diurnal Intermittent Fasting on Hypoglycemic Events in Patients With Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials and Observational Studies.
    Abdelrahim D; Faris ME; Hassanein M; Shakir AZ; Yusuf AM; Almeneessier AS; BaHammam AS
    Front Endocrinol (Lausanne); 2021; 12():624423. PubMed ID: 33763029
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Strategies to Make Ramadan Fasting Safer in Type 2 Diabetics: A Systematic Review and Network Meta-analysis of Randomized Controlled Trials and Observational Studies.
    Lee SWH; Lee JY; Tan CSS; Wong CP
    Medicine (Baltimore); 2016 Jan; 95(2):e2457. PubMed ID: 26765440
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Safety Assessment of Glucose-Lowering Drugs and Importance of Structured Education during Ramadan: A Systematic Review and Meta-Analysis.
    Shiju R; Akhil A; Thankachan S; Tuomilehto J; Al Arouj M; Bennakhi A
    J Diabetes Res; 2022; 2022():3846253. PubMed ID: 35242880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The impact of Ramadan fasting on metabolic profile among type 2 diabetes mellitus patients: A meta-analysis.
    Tahapary DL; Astrella C; Kristanti M; Harbuwono DS; Soewondo P
    Diabetes Metab Syndr; 2020; 14(5):1559-1570. PubMed ID: 32947756
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of fasting ramadan in diabetes control status - application of extensive diabetes education, serum creatinine with HbA1c statistical ANOVA and regression models to prevent hypoglycemia.
    Aziz KM
    Recent Pat Endocr Metab Immune Drug Discov; 2013 Sep; 7(3):233-51. PubMed ID: 23964680
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence of hypoglycemia in patients with type 2 diabetes treated with gliclazide versus DPP-4 inhibitors during Ramadan: A meta-analytical approach.
    Mbanya JC; Al-Sifri S; Abdel-Rahim A; Satman I
    Diabetes Res Clin Pract; 2015 Aug; 109(2):226-32. PubMed ID: 26003888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hypoglycemia in patients with type 2 diabetes from India and Malaysia treated with sitagliptin or a sulfonylurea during Ramadan: a randomized, pragmatic study.
    Aravind SR; Ismail SB; Balamurugan R; Gupta JB; Wadhwa T; Loh SM; Suryawanshi S; Davies MJ; Girman CJ; Katzeff HL; Radican L; Engel SS; Wolthers T
    Curr Med Res Opin; 2012 Aug; 28(8):1289-96. PubMed ID: 22738801
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment Options for Patients with Type 2 Diabetes Mellitus during the Fasting Month of Ramadan.
    Loh HH; Kamaruddin NA
    Ann Acad Med Singap; 2020 Jul; 49(7):468-476. PubMed ID: 33000110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ramadan Education and Awareness in Diabetes (READ) programme for Muslims with Type 2 diabetes who fast during Ramadan.
    Bravis V; Hui E; Salih S; Mehar S; Hassanein M; Devendra D
    Diabet Med; 2010 Mar; 27(3):327-31. PubMed ID: 20536496
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effects of long term fasting in Ramadan on glucose regulation in type 2 diabetes mellitus.
    Karatoprak C; Yolbas S; Cakirca M; Cinar A; Zorlu M; Kiskac M; Cikrikcioglu MA; Erkoc R; Tasan E
    Eur Rev Med Pharmacol Sci; 2013 Sep; 17(18):2512-6. PubMed ID: 24089232
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ramadan fasting in diabetes patients on insulin pump therapy augmented by continuous glucose monitoring: an observational real-life study.
    Khalil AB; Beshyah SA; Abu Awad SM; Benbarka MM; Haddad M; Al-Hassan D; Kahwatih M; Nagelkerke N
    Diabetes Technol Ther; 2012 Sep; 14(9):813-8. PubMed ID: 22827507
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effect of vildagliptin relative to sulfonylurea as dual therapy with metformin (or as monotherapy) in Muslim patients with type 2 diabetes fasting during Ramadan in the Middle East: the VIRTUE study.
    Hassoun AA; Al-Arouj M; Ibrahim M
    Curr Med Res Opin; 2017 Jan; 33(1):161-167. PubMed ID: 27684469
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The characteristics and pattern of care for the type 2 diabetes mellitus population in the MENA region during Ramadan: An international prospective study (DAR-MENA T2DM).
    Hassanein M; Al Awadi FF; El Hadidy KES; Ali SS; Echtay A; Djaballah K; Dessapt-Baradez C; Khazaal FAK; Abu-Hijleh MO; Al Shaikh A; Gharbi MEH; Shehadeh N; Bennakhi A; Al Arouj M
    Diabetes Res Clin Pract; 2019 May; 151():275-284. PubMed ID: 30825560
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A systematic review on efficacy and safety of the current hypoglycemic agents in patients with diabetes during Ramadan fasting.
    Rashid F; Abdelgadir E
    Diabetes Metab Syndr; 2019; 13(2):1413-1429. PubMed ID: 31336501
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tolerability of canagliflozin in patients with type 2 diabetes mellitus fasting during Ramadan: Results of the Canagliflozin in Ramadan Tolerance Observational Study (CRATOS).
    Hassanein M; Echtay A; Hassoun A; Alarouj M; Afandi B; Poladian R; Bennakhi A; Nazar M; Bergmans P; Keim S; Hamilton G; Azar ST
    Int J Clin Pract; 2017 Oct; 71(10):. PubMed ID: 28851109
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Optimizing Ramadan fasting: A randomised controlled trial for people with type 2 diabetes during Ramadan applying the principles of the ADA/EASD consensus.
    Ibrahim M; Barker MM; Ahmad E; Ahmed A; Annabi FA; Ba-Essa EM; Davies MJ; Houeiss P; Iraqi H; Masood SN; Mimouni-Zerguini S; Shaikh S; Tantawi H; Tuomilehto J
    Diabetes Metab Res Rev; 2023 Mar; 39(3):e3604. PubMed ID: 36547366
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy and safety of the newer oral hypoglycemic agents in patients with T2DM during Ramadan: A systematic review and meta-analysis.
    Gad H; Hayat T; Al-Muhannadi H; Malik BR; Mussleman P; Malik RA
    Diabetes Res Clin Pract; 2021 Feb; 172():108562. PubMed ID: 33271228
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of provision of optimum diabetes care on the safety of fasting in Ramadan in adult and adolescent patients with type 1 diabetes mellitus.
    Alawadi F; Alsaeed M; Bachet F; Bashier A; Abdulla K; Abuelkheir S; Rashid F; Abdulaziz Bin Hussain A; Abdelgadir E; Alsayyah F; Elsayed M; Hassanein M
    Diabetes Res Clin Pract; 2020 Nov; 169():108466. PubMed ID: 32971155
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Outcome of focused pre-Ramadan education on metabolic and glycaemic parameters in patients with type 2 diabetes mellitus.
    El Toony LF; Hamad DA; Omar OM
    Diabetes Metab Syndr; 2018 Sep; 12(5):761-767. PubMed ID: 29729978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety and effectiveness of iGlarLixi in adults with type 2 diabetes mellitus from Gulf countries during Ramadan holy month: A subgroup analysis of the SoliRam observational study.
    Hassanein M; El Naggar A; Al Sheikh A; Djaballah K; Saeed M; Melas-Melt L; AlSifri S
    Diabetes Res Clin Pract; 2024 Mar; 209():111567. PubMed ID: 38341039
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.